Research & development increased 21.7%
Research & development changed +21.7% from the comparable as-filed period.
$1.5B→$1.8B2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →REGN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure increased 49.1%
Capital expenditure changed +49.1% from the comparable as-filed period.
$201.4M→$300.2M2 prior comparisons
R&D / revenue moved 421 bp lower
R&D / revenue changed -421 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
39.29%→35.08%2 prior comparisons
Current ratio decreased 17.5%
Current ratio changed -17.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
4.06→3.354 prior comparisons
Operating cash flow increased 10.2%
Operating cash flow changed +10.2% from the comparable as-filed period.
$1.6B→$1.8B2 prior comparisons
Receivables / revenue moved 334 bp lower
Receivables / revenue changed -334 basis points from the comparable as-filed period.
151.48%→148.14%2 prior comparisons
Working capital increased 7.7%
Working capital changed +7.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$13.6B→$14.6B4 prior comparisons
Operating cash-flow margin moved 826 bp lower
Operating cash-flow margin changed -826 basis points from the comparable as-filed period.
43.12%→34.86%2 prior comparisons
Free-cash-flow margin moved 876 bp lower
Free-cash-flow margin changed -876 basis points from the comparable as-filed period.
37.75%→28.99%2 prior comparisons
SBC / revenue moved 131 bp lower
SBC / revenue changed -131 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
6.31%→5.00%2 prior comparisons
Free-cash-flow proxy increased 4.6%
Free-cash-flow proxy changed +4.6% from the comparable as-filed period.
$1.4B→$1.5B2 prior comparisons
Total assets increased 10.5%
Total assets changed +10.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$40.2B→$44.4B4 prior comparisons
Inventory decreased 11.1%
Inventory changed -11.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$3.3B→$2.9B4 prior comparisons
Capex / revenue moved 50 bp higher
Capex / revenue changed +50 basis points from the comparable as-filed period.
5.36%→5.87%2 prior comparisons
Working capital / assets moved 88 bp lower
Working capital / assets changed -88 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
33.75%→32.86%4 prior comparisons
Stock-based compensation increased 7.9%
Stock-based compensation changed +7.9% from the comparable as-filed period.
$237.0M→$255.8M2 prior comparisons
Noncurrent long-term debt increased 0.1%
Noncurrent long-term debt changed +0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.0B→$2.0B4 prior comparisons
Selling, general & administrative increased 3.0%
Selling, general & administrative changed +3.0% from the comparable as-filed period.
$657.8M→$677.8M2 prior comparisons
Cash & equivalents increased 23.0%
Cash & equivalents changed +23.0% from the comparable as-filed period.
$2.0B→$2.5B2 prior comparisons
Operating margin moved 78 bp higher
Operating margin changed +78 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
29.37%→30.15%2 prior comparisons
Working capital / assets moved 357 bp lower
Working capital / assets changed -357 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
34.52%→30.95%4 prior comparisons
Research & development increased 14.8%
Research & development changed +14.8% from the comparable as-filed period.
$1.4B→$1.6B2 prior comparisons
Operating cash-flow margin moved 1219 bp lower
Operating cash-flow margin changed -1219 basis points from the comparable as-filed period.
31.14%→18.95%2 prior comparisons
Free-cash-flow margin moved 1183 bp lower
Free-cash-flow margin changed -1183 basis points from the comparable as-filed period.
25.18%→13.35%2 prior comparisons
SBC / revenue moved 118 bp lower
SBC / revenue changed -118 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
6.85%→5.66%2 prior comparisons
Total assets increased 9.2%
Total assets changed +9.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$38.2B→$41.7B4 prior comparisons
Working capital decreased 2.1%
Working capital changed -2.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$13.2B→$12.9B4 prior comparisons
Capex / revenue moved 36 bp lower
Capex / revenue changed -36 basis points from the comparable as-filed period.
5.96%→5.60%2 prior comparisons
Stock-based compensation decreased 3.5%
Stock-based compensation changed -3.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$251.7M→$243.0M3 prior comparisons
Capital expenditure increased 9.7%
Capital expenditure changed +9.7% from the comparable as-filed period.
$219.0M→$240.2M3 prior comparisons
R&D / revenue moved 65 bp lower
R&D / revenue changed -65 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
38.68%→38.03%2 prior comparisons
Inventory decreased 3.8%
Inventory changed -3.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$3.2B→$3.1B4 prior comparisons
Noncurrent long-term debt increased 0.1%
Noncurrent long-term debt changed +0.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$2.0B→$2.0B4 prior comparisons
Selling, general & administrative increased 4.4%
Selling, general & administrative changed +4.4% from the comparable as-filed period.
$634.2M→$662.1M2 prior comparisons
Receivables / revenue moved 39 bp higher
Receivables / revenue changed +39 basis points from the comparable as-filed period.
152.63%→153.01%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.